Cargando…
Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation
Cytochrome P450 (CYP) enzymes metabolize arachidonic acid to vasoactive eicosanoids such as epoxyeicosatrienoic acids (EETs) and 20-Hydroxyeicosatetraenoic acid (20-HETE), whilst soluble epoxide hydrolase, encoded by the EPHX2 gene, is in charge of EETs degradation. We aimed to analyze the influence...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797116/ https://www.ncbi.nlm.nih.gov/pubmed/31622444 http://dx.doi.org/10.1371/journal.pone.0224129 |
_version_ | 1783459746724970496 |
---|---|
author | Mota-Zamorano, Sonia González, Luz M. Luna, Enrique Fernández, José J. Gómez, Áurea Nieto-Fernández, Alberto Robles, Nicolás R. Gervasini, Guillermo |
author_facet | Mota-Zamorano, Sonia González, Luz M. Luna, Enrique Fernández, José J. Gómez, Áurea Nieto-Fernández, Alberto Robles, Nicolás R. Gervasini, Guillermo |
author_sort | Mota-Zamorano, Sonia |
collection | PubMed |
description | Cytochrome P450 (CYP) enzymes metabolize arachidonic acid to vasoactive eicosanoids such as epoxyeicosatrienoic acids (EETs) and 20-Hydroxyeicosatetraenoic acid (20-HETE), whilst soluble epoxide hydrolase, encoded by the EPHX2 gene, is in charge of EETs degradation. We aimed to analyze the influence of common, functional polymorphisms in four genes of the donor on the renal biopsy scores independently assigned by pathologists. Additionally, we examined whether this score or the presence of these SNPs were independent risk factors of clinical outcomes in the first year after grafting. A cohort of 119 recipients and their corresponding 85 deceased donors were included in the study. Donors were genotyped for the CYP4F2 V433M, CYP2C8*3, CYP2J2*7, EPHX2 3’UTR A>G, EPHX2 K55R and EPHX2 R287Q polymorphisms. The association of the donors’ SNPs with the biopsy scores and clinical outcomes was retrospectively evaluated by multivariate regression analysis. The CYP2C8*3 polymorphism in the donor was significantly associated with higher scores assigned to pretransplant biopsies [OR = 3.35 (1.03–10.93), p = 0.045]. In turn, higher scores were related to an increased risk of acute rejection [OR = 5.28 (1.32–21.13), p = 0.019] and worse glomerular filtration rate (eGFR) (45.68±16.05 vs. 53.04±16.93 ml/min in patients whose grafts had lower scores, p = 0.010) one year after transplant. Patients whose donors carried the CYP4F2 433M variant showed lower eGFR values (48.96±16.89 vs. 55.94±18.62 ml/min in non-carriers, p = 0.038) and higher risk of acute rejection [OR = 6.18 (1.03–37.21), p = 0.047]. The CYP2J2*7 SNP in the donor was associated with elevated risk of delayed graft function [OR = 25.68 (1.52–43.53), p = 0.025]. Our results taken together suggest that donor genetic variability may be used as a predictor of tissue damage in the graft as well as to predict clinical outcomes and graft function in the recipient. |
format | Online Article Text |
id | pubmed-6797116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-67971162019-10-20 Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation Mota-Zamorano, Sonia González, Luz M. Luna, Enrique Fernández, José J. Gómez, Áurea Nieto-Fernández, Alberto Robles, Nicolás R. Gervasini, Guillermo PLoS One Research Article Cytochrome P450 (CYP) enzymes metabolize arachidonic acid to vasoactive eicosanoids such as epoxyeicosatrienoic acids (EETs) and 20-Hydroxyeicosatetraenoic acid (20-HETE), whilst soluble epoxide hydrolase, encoded by the EPHX2 gene, is in charge of EETs degradation. We aimed to analyze the influence of common, functional polymorphisms in four genes of the donor on the renal biopsy scores independently assigned by pathologists. Additionally, we examined whether this score or the presence of these SNPs were independent risk factors of clinical outcomes in the first year after grafting. A cohort of 119 recipients and their corresponding 85 deceased donors were included in the study. Donors were genotyped for the CYP4F2 V433M, CYP2C8*3, CYP2J2*7, EPHX2 3’UTR A>G, EPHX2 K55R and EPHX2 R287Q polymorphisms. The association of the donors’ SNPs with the biopsy scores and clinical outcomes was retrospectively evaluated by multivariate regression analysis. The CYP2C8*3 polymorphism in the donor was significantly associated with higher scores assigned to pretransplant biopsies [OR = 3.35 (1.03–10.93), p = 0.045]. In turn, higher scores were related to an increased risk of acute rejection [OR = 5.28 (1.32–21.13), p = 0.019] and worse glomerular filtration rate (eGFR) (45.68±16.05 vs. 53.04±16.93 ml/min in patients whose grafts had lower scores, p = 0.010) one year after transplant. Patients whose donors carried the CYP4F2 433M variant showed lower eGFR values (48.96±16.89 vs. 55.94±18.62 ml/min in non-carriers, p = 0.038) and higher risk of acute rejection [OR = 6.18 (1.03–37.21), p = 0.047]. The CYP2J2*7 SNP in the donor was associated with elevated risk of delayed graft function [OR = 25.68 (1.52–43.53), p = 0.025]. Our results taken together suggest that donor genetic variability may be used as a predictor of tissue damage in the graft as well as to predict clinical outcomes and graft function in the recipient. Public Library of Science 2019-10-17 /pmc/articles/PMC6797116/ /pubmed/31622444 http://dx.doi.org/10.1371/journal.pone.0224129 Text en © 2019 Mota-Zamorano et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Mota-Zamorano, Sonia González, Luz M. Luna, Enrique Fernández, José J. Gómez, Áurea Nieto-Fernández, Alberto Robles, Nicolás R. Gervasini, Guillermo Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation |
title | Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation |
title_full | Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation |
title_fullStr | Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation |
title_full_unstemmed | Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation |
title_short | Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation |
title_sort | polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797116/ https://www.ncbi.nlm.nih.gov/pubmed/31622444 http://dx.doi.org/10.1371/journal.pone.0224129 |
work_keys_str_mv | AT motazamoranosonia polymorphismsinvasoactiveeicosanoidgenesofkidneydonorsaffectbiopsyscoresandclinicaloutcomesinrenaltransplantation AT gonzalezluzm polymorphismsinvasoactiveeicosanoidgenesofkidneydonorsaffectbiopsyscoresandclinicaloutcomesinrenaltransplantation AT lunaenrique polymorphismsinvasoactiveeicosanoidgenesofkidneydonorsaffectbiopsyscoresandclinicaloutcomesinrenaltransplantation AT fernandezjosej polymorphismsinvasoactiveeicosanoidgenesofkidneydonorsaffectbiopsyscoresandclinicaloutcomesinrenaltransplantation AT gomezaurea polymorphismsinvasoactiveeicosanoidgenesofkidneydonorsaffectbiopsyscoresandclinicaloutcomesinrenaltransplantation AT nietofernandezalberto polymorphismsinvasoactiveeicosanoidgenesofkidneydonorsaffectbiopsyscoresandclinicaloutcomesinrenaltransplantation AT roblesnicolasr polymorphismsinvasoactiveeicosanoidgenesofkidneydonorsaffectbiopsyscoresandclinicaloutcomesinrenaltransplantation AT gervasiniguillermo polymorphismsinvasoactiveeicosanoidgenesofkidneydonorsaffectbiopsyscoresandclinicaloutcomesinrenaltransplantation |